Terug
Ook genoteerd als
SHTDY
OTC
Dagbereik
€ 2,68
€ 2,68
52-Weeksbereik
€ 2,11
€ 2,70
Volume
200
50D / 200D Gem.
€ 2,47
/
€ 2,37
Vorige Slotkoers
€ 2,63
Koershistorie
Financiële Trends
Sectorvergelijking
vs Healthcare sector mediaan (627 peers)
| Metriek | Aandeel | Sector Mediaan |
|---|---|---|
| P/E | 1,2 | 0,3 |
| P/B | 0,1 | 2,9 |
| ROE % | 9,2 | 3,7 |
| Net Margin % | 1,2 | 3,8 |
| Rev Growth 5Y % | 6,4 | 10,0 |
| D/E | 1,0 | 0,2 |
Koersdoel Analisten
Geen analistendekking beschikbaar
Winstschattingen
| Periode | WPA Sch. | Omzet Sch. | Analisten |
|---|---|---|---|
| FY2027 |
€ 2,44
€ 2,25 – € 2,76
|
590 B | 1 |
| FY2026 |
€ 2,39
€ 2,20 – € 2,70
|
580 B | 1 |
Belangrijkste Punten
Revenue grew 6,38% annually over 5 years — modest growth
Earnings declined -22,14% over the past year
Generating 9,58B in free cash flow
P/E of 1,18 — trading at a low valuation
Revenue growth is decelerating — 1Y growth trails 5Y average by 8,40%
Cash machine — converts 135,86% of earnings into free cash flow
Groei
Revenue Growth (5Y)
6,38%
Revenue (1Y)-2,02%
Earnings (1Y)-22,14%
FCF Growth (3Y)-28,14%
Kwaliteit
Return on Equity
9,19%
ROIC7,82%
Net Margin1,21%
Op. Margin2,77%
Veiligheid
Debt / Equity
0,97
Current Ratio1,39
Interest Coverage5,92
Waardering
P/E Ratio
1,18
P/B Ratio0,11
EV/EBITDA1,88
Dividend Yield0,05%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | -2,02% | Revenue Growth (3Y) | 2,89% |
| Earnings Growth (1Y) | -22,14% | Earnings Growth (3Y) | -9,07% |
| Revenue Growth (5Y) | 6,38% | Earnings Growth (5Y) | -0,48% |
| Profitability | |||
| Revenue (TTM) | 584,51B | Net Income (TTM) | 7,05B |
| ROE | 9,19% | ROA | 1,79% |
| Gross Margin | 7,57% | Operating Margin | 2,77% |
| Net Margin | 1,21% | Free Cash Flow (TTM) | 9,58B |
| ROIC | 7,82% | FCF Growth (3Y) | -28,14% |
| Safety | |||
| Debt / Equity | 0,97 | Current Ratio | 1,39 |
| Interest Coverage | 5,92 | Dividend Yield | 0,05% |
| Valuation | |||
| P/E Ratio | 1,18 | P/B Ratio | 0,11 |
| P/S Ratio | 0,01 | PEG Ratio | -0,36 |
| EV/EBITDA | 1,88 | Dividend Yield | 0,05% |
| Market Cap | 8,35B | Enterprise Value | 30,42B |
Income Statement
Annual, most recent first
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Revenue | 584,51B | 596,57B | 552,15B | 521,05B | 456,41B |
| Net Income | 7,05B | 9,05B | 8,53B | 7,76B | 7,19B |
| EPS (Diluted) | 2,26 | 2,90 | 2,73 | 2,49 | 2,31 |
| Gross Profit | 44,26B | 48,51B | 47,43B | 44,05B | 40,32B |
| Operating Income | 16,19B | 20,21B | 20,60B | 19,71B | 17,76B |
Balance Sheet
Annual, most recent first
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Total Assets | 392,83B | 383,39B | 364,78B | 335,41B | 311,24B |
| Total Liabilities | 266,14B | 263,08B | 254,71B | 235,76B | 221,29B |
| Shareholders' Equity | 78,88B | 74,58B | 68,07B | 61,89B | 56,36B |
| Total Debt | 76,39B | 73,78B | 69,59B | 68,37B | 68,53B |
| Cash & Equivalents | 54,31B | 63,81B | 55,22B | 43,53B | 50,18B |
| Current Assets | 347,45B | 336,84B | 319,41B | 290,92B | 267,61B |
| Current Liabilities | 250,38B | 241,49B | 234,96B | 219,31B | 203,98B |